Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VYNE compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
VYNE
VYNE Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
VYNE
VYNE Therapeutics Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
VYNE revenue flow unavailable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only VYNE
0
None
Shared
0
No disclosed counterparties: VYNE.
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Role chip = supplier or customer
Source: SEC EDGAR
VYNE
VYNE Therapeutics Inc.
Change
17.76
▼
−0.93%
Mkt cap
—
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,422.84
▲
+0.84%
Regular session
Nov 3 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Regular session
Nov 3 '26
VYNE
VYNE Therapeutics Inc.
vs
LLY
ELI Lilly & Co
17.76
▼
−0.93%
Price
1,422.84
▲
+0.84%
—
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
VYNE
17.76
▼
−0.93%
vs
LLY
1,422.84
▲
+0.84%
Regular session
Nov 3 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
VYNE, solid
LLY, dashed